The price of this share is at 0,87$, Gritstone Oncology Inc, with address at 5959 HORTON STREET SUITE 300, EMERYVILLE, California, 94608, United States, is a publicly traded company and its visible heads at the moment are Andrew R. Allen (President, Chief Executive Officer & Director), Erin E. Jones (Chief Operating Officer), Karin Jooss (Head-Research & Development), Matthew Hawryluk (Chief Business Officer & Executive Vice President), Raphadl Rousseau (Chief Medical Officer & Executive Vice President), Vassiliki Celia Economides (Chief Financial Officer & Executive Vice President). Focused on Biotechnology: Biological Products (No Diagnostic Substances) was created long ago in United States.
Yesterday this stock ended the day with a value of desconocido$.
The current range on the same day is from 0,86$ - 0,90$, with a percentage difference of 0,88$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
